All-Cause Mortality and Cardiovascular Outcomes With Prophylactic Steroid Therapy in Duchenne Muscular Dystrophy
Gernot Schram(Montreal Heart Institute), Paul Khairy(University of Kentucky), Michel Vanasse(Centre Hospitalier Universitaire Sainte-Justine), Nagib Dahdah(HTC (Taiwan)), Hugues Leduc(Montreal Heart Institute), Johanne Thérien(Centre Hospitalier Universitaire Sainte-Justine), Anne Fournier(Centre Hospitalier Universitaire Sainte-Justine)
Cited by 220
Related Papers
The long QT syndrome in children. An international study of 287 patients.
|Circulation|1993|397
Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease
|Nature Genetics|2011|355
New Equations and a Critical Appraisal of Coronary Artery Z Scores in Healthy Children
|Journal of the American Society of Echocardiography|2010|309
Increased mortality among patients taking digoxin--analysis from the AFFIRM study
|European Heart Journal|2012|280
Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: Executive summary
|Canadian Journal of Cardiology|2010|201